The multiple sclerosis fellow at Michigan Institute for Neurologic Disorders provided perspective on the clinical utility and advantages of a multi-protein test that assesses multiple sclerosis disease activity. [WATCH TIME: 3 minutes]
Taylor Gonyou, DO
Advertisement
Articles by Taylor Gonyou, DO
Advertisement
Latest Updated Articles
Gauging MS Disease Activity Through Octave’s MSDA Test: Taylor Gonyou, DOPublished: February 24th 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O'Shea, MD, MSc
2
De-Escalation Strategies in Multiple Sclerosis: Oral Therapies and Cladribine
3
Early Results Show Symptom Gains in First Patient Dosed With UX-DA001 Cell Therapy for Parkinson Disease
4
Bringing Biomarkers to the Bedside: The Clinical Promise of Abbott’s TBI Test
5
